A progressive liver condition affects thousands of Americans, but early symptoms are often dismissed as everyday ailments.

Feeling a little itchy? Here's how to recognize the most commonly undiagnosed skin irritations, including the one you may ...

Akero Therapeutics shares gained 106% before the bell on Monday after the company reported results from a mid-stage trial studying its lead drug in patients with a type of liver disease.